Table 1.
Overview of studies applying mass cytometry together with single-cell RNA-sequencing to study human cancer heterogeneity.
| References | Methods for single-cell profiling | Cancer type | Integration stage |
|---|---|---|---|
| Lavin et al. 2017 (52) | Mass cytometry and scRNA-seq | Lung cancer | Late |
| De Vries et al. 2019 (57) | Mass cytometry and scRNA-seq | Colorectal cancer | Late |
| Zhang et al. 2019 (61) | Mass cytometry and scRNA-seq | Liver cancer | Late |
| Sankowski et al. 2019 (49) | Mass cytometry and scRNA-seq | Glioma | Late |
| Halaby et al. 2019 (55) | Mass cytometry and scRNA-seq | Melanoma | Late |
| Goswami et al. 2020 (50) | Mass cytometry and scRNA-seq | Glioblastoma | Late |
| Goveia et al. 2020 (107) | Mass cytometry and scRNA-seq | Lung cancer | Late |
| Helmink et al. 2020 (56) | Mass cytometry and scRNA-seq | Melanoma | Late |
scRNA-seq, single-cell RNA-sequencing.